Biomarker Research for Personalized Medicine

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2013 by Inje University
Sponsor:
Information provided by (Responsible Party):
Jae-Gook Shin, Inje University
ClinicalTrials.gov Identifier:
NCT01488591
First received: December 6, 2011
Last updated: May 30, 2013
Last verified: May 2013
  Purpose

The aim of this study :

  1. Through the study of genes of protein, transporter, translator and epigenome investigating the effect of anti-cancer treatment or the key factor of the MDR (Multidrug resistance) on the blood cancer patients who are under the anti-cancer sork treatment
  2. Giving a service of anticancer medicine therapeutic drug monitoring (TDM) and genotyping

Condition
Hematologic Neoplasms

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Biomarker Research for Personalized Medicine in Blood Cancer Patient

Resource links provided by NLM:


Further study details as provided by Inje University:

Biospecimen Retention:   Samples With DNA

whole blood


Estimated Enrollment: 1000
Study Start Date: April 2009
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

healthy volunteers

Criteria

Inclusion Criteria:

  • Korean
  • Clinical diagnosis of Hematologic neoplasms
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01488591

Contacts
Contact: Jae Gook Shin, M.D.,Ph.D. 82-51-890-6709 phshinjg@inje.ac.kr

Locations
Korea, Republic of
Inje University Recruiting
Busan, Korea, Republic of, 614-735
Contact: Jae Gook Shin, M.D., Ph.D.    82-51-890-6709    phshinjg@inje.ac.kr   
Sponsors and Collaborators
Inje University
  More Information

No publications provided

Responsible Party: Jae-Gook Shin, Department of Pharmacology and Pharmacogenomics Research Center, Inje University
ClinicalTrials.gov Identifier: NCT01488591     History of Changes
Other Study ID Numbers: 09-029
Study First Received: December 6, 2011
Last Updated: May 30, 2013
Health Authority: Korea: Institutional Review Board

Additional relevant MeSH terms:
Neoplasms
Hematologic Neoplasms
Neoplasms by Site
Hematologic Diseases

ClinicalTrials.gov processed this record on August 01, 2014